Dr. Artzi is an Associate Professor of Medicine at Harvard Medical School. She is a Principal Research Scientist at MIT, Associate Faculty at the Wyss Institute for Biologically Inspired Engineering, Associate Head of Mass General Brigham’s Gene and Cell Therapy Institute, Head of the Center for Genomic Medicine and Structural Immunotherapy, and an Associate Member of the Broad Institute of Harvard and MIT. She completed her postdoctoral studies at MIT focusing on studying tissue:biomaterial interactions and designing smart biomaterials for therapy and diagnosis applications.

Dr. Artzi is the recipient of multiple grants and awards, including an ARPA-H grant on Disease-Agnostic Innate Immunotherapeutic RNA Platform, and prestigious awards including the inaugural Kabiller Rising Star Award in Nanotechnology and Nanomedicine, the Acta Biomaterialia Silver Medal, Society for Biomaterials Clemson Award for Applied Research, One Brave Idea Award, Stepping Strong Innovator, Controlled Release Society Young Investigator Award, Mid-Career Award from the Society for Biomaterials, Bright Futures Prize, and the Massachusetts Life Science Center for Women Entrepreneurs. Dr. Artzi was recently inducted to the Controlled Release Society College of Fellows and the American Institute for Medical and Biological Engineering.

Currently, Dr. Artzi directs multiple research venues aiming to integrate science, engineering, and medicine to rationally design personalized materials to improve human health, and has co-founded a startup company, BioDevek, which develops next-generation biomaterials to improve outcomes following internal surgeries. She is also co-founding Araneus Bio, a company that aims to take technology from the lab to the clinic for the treatment of patients with Glioblastoma.